Proteome analysis of Epstein-Barr virus-transformed B-lymphoblasts and the proteome database.
The proteome is the entire protein complement of the genome expressed in a particular cell, tissue, or organism at a given time under a specific set of environmental conditions. Proteomics is a combinatorial methodology to comprehensively analyze the proteome. The general protocol of the expression proteomics consists of advanced methods of high-resolution protein separation, high-quality image analysis and high-throughput protein identification. Although Epstein-Barr virus-transformed B-lymphoblastoid cell lines (LCLs) have long been believed to be immortalized, recent studies have provided ample evidence that a large proportion of LCLs have limited life spans due to shortening of telomeres, and that part of them are truly immortalized by developing strong telomerase activity to maintain telomeres. Differential proteome analysis of pre- and post-immortal LCLs would provide a powerful tool to analyze proteins participating in the process of immortalization. We focus in this review on cumulative data of proteomic information on pre- and post-immortal LCLs.
Toda
Tosifusa
T
Proteomics Collaboration Center, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho, Itabashiku, Tokyo 173-0015, Japan.
Sugimoto
Masanobu
M
D001402:B-Lymphocytes / Q000378:metabolism* / Q000821:virology; D002472:Cell Transformation, Viral; D030562:Databases, Protein; D015180:Electrophoresis, Gel, Two-Dimensional; D004854:Herpesvirus 4, Human / Q000502:physiology*; D020543:Proteome
D020543:Proteome